One-liner: “Biotx.ai develops AI-driven causal modeling solutions for the biopharma sector, focusing on drug discovery and clinical trial efficacy prediction.”
Company slogan: Unlocking the full therapeutic potential of the human genome through algorithms
Positioning: “Biotx.ai positions itself as a pioneer in causal modeling for drug discovery, leveraging large-scale human genetic data to enhance the efficacy prediction process in clinical trials.”
Description: “biotx.ai delivers predictive biomarkers as a basis for decision support in precision medicine. We use novel, state of the art, machine learning approaches specifically designed to find complex patterns in biomedical data.”
Employees: 12
Website: Visit websiteHeadquarters: “Potsdam, Brandenburg”
Ownership: Privately Held
Founded: 2017
Company type: AI company
Use cases: “drug discovery, clinical trials, biomarker screening”
Pricing: –
Client sector: “biopharma, CROs, pharmaceutical companies”
Business model: “subscription, licensing”
Products: “Causal genome dataset, Efficacy prediction models”
Is API available: no
Website title: BioXcel Therapeutics Inc – BioXcel Therapeutics Inc
Website description: none
Linkedin: https://www.linkedin.com/company/biotx-ai
Youtube: https://www.youtube.com/channel/UCJIa_rCXrB7UyzceMLZCN2Q
Instagram: –
Facebook: –
Twitter: https://twitter.com/biotx_ai
Crunchbase: https://www.crunchbase.com/organization/biotx-ai
Email: info@biotx.ai